TCTR20200820005招募中3 期
0.075% capsaicin lotion for the treatment of peripheral neuropathy in ESRD patient: A randomized double-blind placebo-controlled, cross over trial
Department of Medicine, Phramongkutklao Hospital0 个研究点目标入组 60 人开始时间: 2020年8月20日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1. Age ≥ 20 years old
- •2. End stage renal disease patient
- •3. The scores of neuropathic pain diagnostic questionnaire (Thai DN4) are 4-8
- •4. Participants have moderate neuropathic pain more than 1 month
- •5. Participants who have been using other standard pain control pills, should take the same dose for more than 4 weeks.
排除标准
- •1. Participants who have severe side effect of 0.075% capsicin gel.
研究者
相似试验
已完成
3 期
0.075% Capsaicin Lotion for the Treatment of Painful Diabetic NeuropathyPeripheral Diabetic NeuropathyNCT03113448Thammasat University42
进行中（未招募）
1 期
Topical Capsaicin 0.025% as a treatment for Achilles tendinopathy. A prospective, double blinded, randomised controlled trial with multiple outcome measures.Achilles TendinopathyEUCTR2006-005471-18-GBSheffield Teaching Hospitals NHS Foundation Trust
已完成
不适用
Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis siccaH16.2H04.1KeratoconjunctivitisOther disorders of lacrimal glandDRKS00003269niversitätsklinikum Erlangen der Friedrich-Alexander Universität Erlangen-Nürnberg62
已完成
不适用
Capsaicin pain model with topical 1% ethanolic capsaicin solutioPainNeuropathic painNL-OMON48384Centre for Human Drug Research10
尚未招募
不适用
1% capsaicin solution pain modelNL-OMON20584CHDR10